Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, ...

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

Medically reviewed by Patricia Mikula, PharmD The majority of children and adults who receive the hepatitis B (hep B) virus ...

Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline - - Interim Phase 1b proof-of-concept data, including initial efficacy ...

Measles continues to spread in Texas and other states and has caused the first reported U.S. death from the virus in a decade ...

"Turning to our development candidates designated for partnering, we reported highly encouraging results from two Phase 2 trials in our chronic hepatitis B ("CHB") program demonstrating that VTP-300 ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The Six Nations title fight is in the balance ahead of the final round of fixtures. France kicked off the action on the penultimate weekend with a huge win over Ireland, and it means Les Blues sit ...

The Cheltenham Festival came to an end on Friday as the Gold Cup served up a shock result. Galopin Des Champs went for a third straight victory in the race, looking to become only the fifth horse ...

Hepatitis B can lead to liver disease. But we can prevent and manage this viral infection. Here’s what we know about the ...